Skip to main content
SpringerLink
Log in

Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Levocabastine is a potent antihistamine drug, structurally unrelated to neurotensin. In rat and mouse brain but not in other animal species, it inhibited 60% of the [3H]neurotensin binding displaced by unlabelled neurotensin or neurotensin (8–13).

The levocabastine-sensitive site or “site 1” displayed high affinity properties for levocabastine (IC50=25 nM) and was highly stereospecific (IC50-value higher than 10 μM for one of the isomers). Binding to the “site 1” in rat brain corresponded to the [3H]neurotensin binding displaceable by 1 μM levocabastine, whereas binding to the “site 2” corresponded to the binding displaced by 1 μM neurotensin when the “site 1” was occluded by 1 μM levocabastine.

Both “site 1” and “site 2” appeared to be saturable. Scatchard plots obtained in rat bulbus olfactorius allowed to calculate a K D-values of 7.1 nM and a B max-values of 37.2 fmol/mg original tissue for “site 1”, while “site 2” displayed a K D-value of 0.7 nM and a B max-value of 16.3 fmol/mg original tissue. The regional distributions of both sites showed marked differences. The “site 1” was homogeneously distributed throughout all rat brain areas, whereas the amount of “site 2” binding was markedly different in separate brain areas: bulbus olfactorius and substantia nigra had the highest amounts (8.9 and 7.8 fmol/mg tissue) while cerebellum had the lowest (0.4 fmol/mg tissue).

In spite of its high affinity and stereospecificity, “site 1” has to be considered as an acceptor or recognition site for [3H]neurotensin because of its species-link, low saturability and homogeneous distribution in all rat brain areas.

On the other hand, “site 2” had the characteristics of a physiological receptor: high affinity, saturability in the low nanomolar range and marked regional distribution in rat brain. “Site 2” corresponds therefore most probably to the physiological neurotensin receptor. The foregoing experiments provide evidence for the presence of a drug displaceable, non-specific (=unrelated to a physiological receptor) neurotensin binding site in rat brain; levocabastine should be an important tool to occlude this site in order to reveal, by means of in vitro binding assays, the specific neurotensin binding site in rat brain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bristow DR, Hare JR, Hearn JR, Martin LE (1981) Radioligand binding studies using [3H]cimetidine and [3H]ranitidine. Br J Pharmacol 72:547

    Google Scholar 

  • Carraway R, Leeman SE (1973) The isolation of new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 248:6854–6861

    Google Scholar 

  • Carraway R, Leeman SE (1976) Characterization of radioimmunoassayable neurotensin in the rat; its differential distribution in the central nervous system, small intestine and stomach. J Biol Chem 251:7045–7052

    Google Scholar 

  • Cooper PE, Fernstrom MH, Rorstad OP, Leeman SE, Martin JB (1981) The regional distribution of somatostatin, substance P and neurotensin in human brain. Brain Res 218:219–232

    Google Scholar 

  • Emson PC, Goedert M, Horsfield P, Rioux F, St-Pierre S (1982) The regional distribution and chromatographic characterization of neurotensin-like immunoreactivity in the rat central nervous system. J Neurochem 38:992–999

    Google Scholar 

  • Goedert M (1984) Neurotensin — a status report. TINS 7:3–5

    Google Scholar 

  • Goedert M, Pittaway K, Williams BJ, Emson PC (1984a) Specific binding of tritiated neurotensin to rat brain membranes: characterization and regional distribution. Brain Res 304:71–81

    Google Scholar 

  • Goedert M, Pittaway K, Emson PC (1984b) Neurotensin receptors in the rat striatum: lesion studies. Brain Res 299:164–168

    Google Scholar 

  • Gorissen H, Ilien B, Aerts G, Laduron P (1980) Differentiation of solubilized dopamine receptors from spirodecanone binding sites in rat striatum. FEBS Letters 121:133–138

    Google Scholar 

  • Kitabgi P, Kwan CY, Fox JA, Vincent JP (1984) Characterization of neurotensin binding to rat gastric smooth muscle receptor sites. Peptides 5:917–923

    Google Scholar 

  • Laduron P (1984) Criteria for receptor sites in binding studies. Biochem Pharmacol 33:833–839

    Google Scholar 

  • Lowry OH, Rozebrough NJ, Farr AL, Roudall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • Mazella J, Poustis C, Labbé C, Chécler F, Kitabgi P, Granier C, van Rietschoten J, Vincent JP (1983) Monoiodo—[Trp11]neurotensin, a highly radioactive ligand of neurotensin receptors. J Biol Chem 258:3476–3481

    Google Scholar 

  • McCann SM, Vijayan E, Koenig J, Krulich L (1982) The effects of neurotensin on anterior pituitary hormone secretion. In: Nemeroff ChB, Prange AJ (eds) Neurotensin, a brain and gastro-intestinal peptide. Ann NY Acad Sci 400:160–171

  • Nemeroff Ch, Cain ST (1985) Neurotensin-dopamine interactions in the CNS. TIPS May: 201–205

  • Palacios J, Kuhar M (1981) Neurotensin receptors are located on dopamine containing neurones in rat midbrain. Nature 294:587–589

    Google Scholar 

  • Quirion R (1983) Interactions between neurotensin and dopamine in the brain: an overview. Peptides 4:609–615

    Google Scholar 

  • Quirion R, Regoli D, Rioux F, St-Pierre S (1980) The stimulatory effects of neurotensin and related peptides in rat stomach strips and guinea-pig atria. Br J Pharmacol 68:83–91

    Google Scholar 

  • Rising TJ, Norris DB, Warrander SE, Wood TP (1980) High affinity 3H-cimetidine binding in guinea-pig tissues. Life Sci 27:199–206

    Google Scholar 

  • Sadoul JL, Kitabgi P, Rostène W, Javoy-Agid F, Agid Y, Vincent JP (1984a) Characterization and visualization of neurotensin binding to receptor sites in human brain. Biochem Biophys Res Comm 120:206–213

    Google Scholar 

  • Sadoul JL, Chécler F Kitabgi P, Rostène W, Javoy-Agid F, Vincent JP (1984b) Loss of high affinity neurotensin receptors in substantia nigra from parkinsonian subjects. Biochem Biophys Res Comm 125:395–404

    Google Scholar 

  • Smith IR, Cleverley MT, Ganellin CR, Metters KM (1980) Binding of [3H]cimetidine to rat brain tissue. Agents Actions 10:422–426

    Google Scholar 

  • Stockbroekx RA, Luyckx MG, Willems JJM, Janssen MAC, Bracke JOMM, Joosen RLP, Van Wanne JP (1986) Devocabastine (R 50547), the prototype of a chemical series of compounds with specific H1-antihistaminic activity. Drug Dev Res (in press)

Download references

Author information

Authors and Affiliations

  1. Department of Biochemical Pharmacology, Janssen Pharmaceutica, Turnhoutseweg 30, B-2340, Beerse, Belgium

    A. Schotte, J. E. Leysen & P. M. Laduron

Authors
  1. A. Schotte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. E. Leysen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. M. Laduron
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schotte, A., Leysen, J.E. & Laduron, P.M. Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 333, 400–405 (1986). https://doi.org/10.1007/BF00500016

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00500016

Key words

Search

Navigation